[EN] INDAZOLE DERIVATIVES THAT DOWN-REGULATE THE ESTROGEN RECEPTOR AND POSSESS ANTI-CANCER ACTIVITY<br/>[FR] DÉRIVÉS D'INDAZOLE QUI RÉGULENT NÉGATIVEMENT LE RÉCEPTEUR D'ŒSTROGÈNE ET POSSÈDENT UNE ACTIVITÉ ANTICANCÉREUSE
申请人:ASTRAZENECA AB
公开号:WO2017182495A1
公开(公告)日:2017-10-26
The specification relates to compounds of Formula (I) and pharmaceutically acceptable salts thereof. The specification also relates to processes and intermediates used for their preparation, pharmaceutical compositions containing them and their use in the treatment of cell proliferative disorders.
该规范涉及到公式(I)的化合物及其药用盐。该规范还涉及到用于它们制备的工艺和中间体,含有它们的药物组合物以及它们在治疗细胞增殖紊乱中的应用。